View our COVID-19 page for general advice, where to get COVID-19 tests, and visiting guidelines for our hospital services.
See for the latest information about COVID-19 vaccinations in Canterbury.

Crohn’s Disease

Summary of official information request

Total number of patients with Crohn's disease of ulcerative colitis to receive biologic treatments (infliximab, adalumimab) between 2016 and 2020 inclusive who were:

  • White New Zealander
  • Maori
  • Asian (Ideally separated into South Asian and East Asian)
  • Pacific Islanders by each ethnicity separately


Download (pdf, 400KB)

Back to Document Library

Page last updated: 16 August 2021

Is this page useful?